This year, alarmingly, Chakraborty saw in his patients new symptoms. For instance, while the symptoms corresponded to the dengue virus, blood tests did not confirm it as dengue positive. Chakraborty opines that at that stage itself one should administer intravenous hydration, as the mere absence of Coryza (inflammation of the mucous membrane in the nose) should be taken as enough indication to initiate treatment, because dehydration occurs at a febrile phase, and any delay in treatment may cause leakage of body fluid (capillary leak), pushing the patient to a critical stage. He cautions that “dengue is a seasonal but regular phenomenon in tropical and sub-tropical areas, and its virus is continuously adapting itself through mutation. So, we must have a dedicated viral laboratory to study it continuously.”